The FDA’s database entry for application number ANDA089465 indicates that the injectable product Wellcovorin has been marked as discontinued.
Wellcovorin is an injectable formulation (route: injection) containing Leucovorin Calcium equivalent to 50 mg base per vial. The product is listed under product number 001 and is not a reference drug or reference standard.
The sponsor for this application is GlaxoSmithKline. The marketing status is recorded as discontinued, meaning the product is no longer marketed in the United States.
Regulatory UpdatesSep 16, 2026•3 min read
FDA Discontinues Wellcovorin Injection (ANDA089465)
The FDA records show that the injectable product Wellcovorin, containing Leucovorin Calcium (50 mg per vial), has been marked as discontinued under ANDA089465.
Compiled by the Pharmacountry team · Source: FDA.gov
Topics:
Ratings
(0)
(0)
(0)
(0)
(0)
Leave your rating